• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

• Solvents and Organic Chemicals Organic Compounds Organometallic compounds Organometalloid compounds Organosilicon compounds Alkylsilanes

Introduction to (3-Chloro-3-methylbut-1-yn-1-yl)trimethylsilane (CAS No. 18387-63-8)

(3-Chloro-3-methylbut-1-yn-1-yl)trimethylsilane, identified by its CAS number 18387-63-8, is a specialized organosilicon compound that has garnered significant attention in the field of synthetic chemistry and pharmaceutical research. This compound, characterized by its unique structure, exhibits a versatile reactivity that makes it a valuable intermediate in the synthesis of complex molecules. Its molecular formula, C?H??ClSi, reflects a combination of carbon, hydrogen, chlorine, and silicon atoms, which contribute to its distinct chemical properties.

The utility of (3-Chloro-3-methylbut-1-yn-1-yl)trimethylsilane stems from its ability to participate in various organic transformations, including nucleophilic substitution reactions, cross-coupling reactions, and silane-mediated reactions. These reactions are fundamental in the construction of carbon-carbon and carbon-heteroatom bonds, which are essential for the development of novel pharmaceuticals and agrochemicals. The presence of a terminal alkyne group and a chlorosilane moiety provides multiple sites for functionalization, making it a versatile building block in synthetic chemistry.

In recent years, there has been a surge in research focused on the development of novel methodologies for constructing complex molecular architectures. Among these methodologies, organosilicon compounds have emerged as pivotal reagents due to their ability to facilitate efficient and selective transformations. (3-Chloro-3-methylbut-1-yn-1-yl)trimethylsilane has been particularly studied for its role in facilitating the synthesis of biologically active compounds. For instance, its application in the preparation of substituted alkenes and alkynes has been explored as a means to generate intermediates for drug discovery.

One of the most notable applications of (3-Chloro-3-methylbut-1-yn-1-yl)trimethylsilane is in the synthesis of heterocyclic compounds, which are prevalent in many pharmaceuticals. Researchers have leveraged its reactivity to introduce functional groups at specific positions within heterocyclic frameworks, thereby modulating their biological activity. This approach has been particularly useful in the development of antiviral and anticancer agents. The compound's ability to undergo regioselective reactions ensures that functionalization occurs at desired sites, minimizing unwanted side products and improving overall yields.

The silane moiety in (3-Chloro-3-methylbut-1-yn-1-yl)trimethylsilane also contributes to its utility as a protecting group or a leaving group in various synthetic protocols. Silanes can be selectively removed under specific conditions, allowing for precise control over reaction outcomes. This feature is particularly valuable in multi-step syntheses where sequential functionalization is required. The stability of the trimethylsilyl (TMS) group under harsh conditions makes it an ideal choice for protecting sensitive functional groups during synthetic transformations.

Recent advances in catalytic systems have further expanded the applications of organosilicon compounds like (3-Chloro-3-methylbut-1-yn-1-ylltrimethylsilane. Transition metal-catalyzed reactions, such as palladium-catalyzed cross-coupling reactions, have enabled the efficient construction of complex molecular architectures from simpler precursors. These reactions often require specialized reagents to facilitate coupling between different organic fragments. The unique reactivity of (3-Chloro-3-methylbut-1-ylltrimethylsilane makes it an excellent candidate for such transformations, contributing to the rapid assembly of pharmacologically relevant molecules.

The synthesis of complex natural products has also benefited from the use of (3-Chloro-3-methylbut-ylltrimethylsilane. Natural products often feature intricate stereochemical arrangements that are challenging to replicate through traditional synthetic methods. Organosilicon compounds provide access to novel synthetic pathways that can overcome these challenges by enabling selective functionalization and stereoselective transformations. This has been particularly useful in the total synthesis of complex biomolecules with significant therapeutic potential.

In conclusion, (3-Chloro--methylbut-ylltrimethylsilane (CAS No. 18387--63--8) is a multifaceted organosilicon compound with broad applications in synthetic chemistry and pharmaceutical research. Its unique structure and reactivity make it an invaluable tool for constructing complex molecular architectures, particularly in the development of biologically active compounds. As research continues to evolve, it is likely that new applications for this compound will emerge, further solidifying its importance in the chemical sciences.

• 83662-45-7(Silane, [(1-chlorocyclopropyl)ethynyl]trimethyl-)
• 18306-51-9(Silane, (6-chloro-3,3,6-trimethyl-1,4-heptadiynyl)trimethyl-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)